Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px
Document › Details

Rentschler Biopharma SE. (12/17/18). "Press Release: Rentschler Biopharma SE to Purchase U.S. Manufacturing Site from Shire plc". Laupheim & Milford, MA.

Organisations Organisation Rentschler Biopharma Inc.
  Group Rentschler (Group)
  Organisation 2 Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ)
  Today Shire Ltd. (LSE: SHP, NASDAQ: SHPGY)
  Group Takeda (Group)
Products Product contract manufacturing (drugs)
  Product 2 contract manufacturing (biologicals)
Index terms Index term Shire–Rentschler: investment, 201812–201901 acquisition €na of Shire’s manufacturing facility in Milford, MA by Rentschler Biopharma SE
  Index term 2 Takeda–Rentschler: biologics contract manufacturing, 201901– supply service continued production for Shire in acquired manufacturing site in Milford
Persons Person Sälzle, Martina (Rentschler 201812 Corporate Communications)
  Person 2 Kaiser, Cora (Rentschler 201903– Senior Director Corp Communications before MC Services + College Hill Munich)
     


Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today that the Company has signed an agreement to purchase a manufacturing facility from an affiliate Shire plc in Milford near Boston, MA, USA.

The development and manufacturing site will be leveraged as a CDMO by Rentschler Biopharma. Under the terms of the agreement, Rentschler Biopharma will continue to manufacture product for Shire at the site.

The closing of the transaction is subject to the prior satisfaction or waiver of certain closing conditions. Financial terms of the transaction were not disclosed.


About Rentschler Biopharma SE

Rentschler Biopharma SE, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO), focused exclusively on clients' projects. Rentschler Biopharma offers process development and manufacturing of biopharmaceuticals as well as related consulting activities, including project management and regulatory support. Rentschler Biopharma's high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy and advanced technologies ensure product quality and productivity at each development and manufacturing step. In order to offer optimal solutions across the entire value chain, the company has entered into a strategic alliance for formulation development with Leukocare AG and into a strategic partnership for fill & finish with Rentschler Fill Solutions GmbH. Rentschler Biopharma is a family-owned company employing more than 850 people. For further information, please visit www.rentschler-biopharma.com.


Contact:

Rentschler Biopharma SE
Martina Sälzle
+49-7392-701-215
communications@rentschler-biopharma.com

MC Services AG
Dr. Cora Kaiser
+49-89-210228-38
rentschler@mc-services.eu

   
Record changed: 2019-11-09

Advertisement

Picture [iito] – Putting Information into Context 650x65px

More documents for Rentschler (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top